For years, there were few treatment options for patients
A recent meta-analysis by Apperloo and colleagues provides evidence that addition of an SGLT2 inhibitor to a GLP-1 receptor agonist effectively reduces cardiovascular events and progression of chronic kidney disease in high-risk type 2 diabetes patients
Despite the common perception that GLP-1 use is an easy way out for weight loss, the reality is much more complicated, according to current or recent users of these medications interviewed for a small new study
Tyna, I feel like we could go on and on
Read on to learn more about this class of medications, how they work, their role in weight loss, and other health benefits they offer
Detoxifies the Liver Through GST enzymes, it binds to toxins, drugs, and pollutants to make them water-soluble for excretion